Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 4 member 11 (SLC4A11), widely known as the sodium-coupled borate cotransporter 1 (NaBC1), is a multi-pass transmembrane protein essential for maintaining the physiological state of specialized tissues such as the cornea and the inner ear. Although its role as a primary borate transporter remains a subject of ongoing research, SLC4A11 is established as a conductor of protons (H+), hydroxyl ions (OH-), and possibly ammonia (NH3), which are critical for intracellular pH regulation and osmotic balance. In the corneal endothelium, SLC4A11 functions as part of a metabolic pump that keeps the corneal stroma dehydrated, thereby preserving its transparency. Mutations in the gene encoding SLC4A11 lead to debilitating disorders including congenital hereditary endothelial dystrophy (CHED) and Harboyan syndrome, the latter of which involves both visual loss and progressive sensorineural deafness. While there are currently no FDA-approved drugs that specifically target SLC4A11, it is a significant focus of therapeutic development, particularly through the use of chemical chaperones to rescue protein folding in dystrophic conditions and gene replacement strategies.
SLC4A11 facilitates the electrogenic transport of borate and the flux of protons (H+) or hydroxyl ions (OH-) across the plasma membrane, maintaining the osmotic balance and pH necessary for cellular health and tissue transparency.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 4 member 11 (SLC4A11) (SLC4A11).